Global Asthma & COPD Market Insights, Forecast to 2025

Publisher Name :
Date: 13-May-2019
No. of pages: 112
Inquire Before Buying

Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.

Asthma is usually considered a separate respiratory disease, but sometimes it's mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.

Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.

The global Asthma & COPD market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Asthma & COPD market based on company, product type, end user and key regions.

This report studies the global market size of Asthma & COPD in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma & COPD in these regions.

This research report categorizes the global Asthma & COPD market by top players/brands, region, type and end user. This report also studies the global Asthma & COPD market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- GSK

- Novartis

- Merck

- Abbott

- Boehringer Ingelheim

- AstraZeneca

- Roche

- Teva

- Vectura

- Pfizer

- Mylan

- Allergan

- Cipla

- Akorn

Market size by Product

- Anti-inflammatory Drugs

- Bronchodilator Monotherapy

- Combination Drugs

Market size by End User

- Hospital Pharmacies

- Private Clinics

- Drug Stores

- Retail Pharmacies

- E-Commerce

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Asthma & COPD market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Asthma & COPD market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Asthma & COPD companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Asthma & COPD submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Asthma & COPD are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Asthma & COPD market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Asthma & COPD Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Asthma & COPD Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Asthma & COPD Market Size Growth Rate by Product
1.4.2 Anti-inflammatory Drugs
1.4.3 Bronchodilator Monotherapy
1.4.4 Combination Drugs
1.5 Market by End User
1.5.1 Global Asthma & COPD Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Private Clinics
1.5.4 Drug Stores
1.5.5 Retail Pharmacies
1.5.6 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Asthma & COPD Market Size
2.1.1 Global Asthma & COPD Revenue 2014-2025
2.1.2 Global Asthma & COPD Sales 2014-2025
2.2 Asthma & COPD Growth Rate by Regions
2.2.1 Global Asthma & COPD Sales by Regions
2.2.2 Global Asthma & COPD Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Asthma & COPD Sales by Manufacturers
3.1.1 Asthma & COPD Sales by Manufacturers
3.1.2 Asthma & COPD Sales Market Share by Manufacturers
3.1.3 Global Asthma & COPD Market Concentration Ratio (CR5 and HHI)
3.2 Asthma & COPD Revenue by Manufacturers
3.2.1 Asthma & COPD Revenue by Manufacturers (2014-2019)
3.2.2 Asthma & COPD Revenue Share by Manufacturers (2014-2019)
3.3 Asthma & COPD Price by Manufacturers
3.4 Asthma & COPD Manufacturing Base Distribution, Product Types
3.4.1 Asthma & COPD Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Asthma & COPD Product Type
3.4.3 Date of International Manufacturers Enter into Asthma & COPD Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Asthma & COPD Sales by Product
4.2 Global Asthma & COPD Revenue by Product
4.3 Asthma & COPD Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Asthma & COPD Breakdown Data by End User
6 North America
6.1 North America Asthma & COPD by Countries
6.1.1 North America Asthma & COPD Sales by Countries
6.1.2 North America Asthma & COPD Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Asthma & COPD by Product
6.3 North America Asthma & COPD by End User
7 Europe
7.1 Europe Asthma & COPD by Countries
7.1.1 Europe Asthma & COPD Sales by Countries
7.1.2 Europe Asthma & COPD Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Asthma & COPD by Product
7.3 Europe Asthma & COPD by End User
8 Asia Pacific
8.1 Asia Pacific Asthma & COPD by Countries
8.1.1 Asia Pacific Asthma & COPD Sales by Countries
8.1.2 Asia Pacific Asthma & COPD Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Asthma & COPD by Product
8.3 Asia Pacific Asthma & COPD by End User
9 Central & South America
9.1 Central & South America Asthma & COPD by Countries
9.1.1 Central & South America Asthma & COPD Sales by Countries
9.1.2 Central & South America Asthma & COPD Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Asthma & COPD by Product
9.3 Central & South America Asthma & COPD by End User
10 Middle East and Africa
10.1 Middle East and Africa Asthma & COPD by Countries
10.1.1 Middle East and Africa Asthma & COPD Sales by Countries
10.1.2 Middle East and Africa Asthma & COPD Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Asthma & COPD by Product
10.3 Middle East and Africa Asthma & COPD by End User
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Business Overview
11.1.3 GSK Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GSK Asthma & COPD Products Offered
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Business Overview
11.2.3 Novartis Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis Asthma & COPD Products Offered
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Asthma & COPD Products Offered
11.3.5 Merck Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Company Business Overview
11.4.3 Abbott Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Abbott Asthma & COPD Products Offered
11.4.5 Abbott Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Ingelheim Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Boehringer Ingelheim Asthma & COPD Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 Company Business Overview
11.6.3 AstraZeneca Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AstraZeneca Asthma & COPD Products Offered
11.6.5 AstraZeneca Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Company Business Overview
11.7.3 Roche Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Roche Asthma & COPD Products Offered
11.7.5 Roche Recent Development
11.8 Teva
11.8.1 Teva Company Details
11.8.2 Company Business Overview
11.8.3 Teva Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Teva Asthma & COPD Products Offered
11.8.5 Teva Recent Development
11.9 Vectura
11.9.1 Vectura Company Details
11.9.2 Company Business Overview
11.9.3 Vectura Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Vectura Asthma & COPD Products Offered
11.9.5 Vectura Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Company Business Overview
11.10.3 Pfizer Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Pfizer Asthma & COPD Products Offered
11.10.5 Pfizer Recent Development
11.11 Mylan
11.12 Allergan
11.13 Cipla
11.14 Akorn
12 Future Forecast
12.1 Asthma & COPD Market Forecast by Regions
12.1.1 Global Asthma & COPD Sales Forecast by Regions 2019-2025
12.1.2 Global Asthma & COPD Revenue Forecast by Regions 2019-2025
12.2 Asthma & COPD Market Forecast by Product
12.2.1 Global Asthma & COPD Sales Forecast by Product 2019-2025
12.2.2 Global Asthma & COPD Revenue Forecast by Product 2019-2025
12.3 Asthma & COPD Market Forecast by End User
12.4 North America Asthma & COPD Forecast
12.5 Europe Asthma & COPD Forecast
12.6 Asia Pacific Asthma & COPD Forecast
12.7 Central & South America Asthma & COPD Forecast
12.8 Middle East and Africa Asthma & COPD Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Asthma & COPD Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Asthma & COPD Product Picture
Table Asthma & COPD Market Segments
Table Key Manufacturers Asthma & COPD Covered
Table Global Asthma & COPD Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Asthma & COPD Sales Market Share by Product 2014-2025
Figure Anti-inflammatory Drugs Product Picture
Table Major Manufacturers of Anti-inflammatory Drugs
Figure Bronchodilator Monotherapy Product Picture
Table Major Manufacturers of Bronchodilator Monotherapy
Figure Combination Drugs Product Picture
Table Major Manufacturers of Combination Drugs
Table Global Asthma & COPD Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital Pharmacies
Figure Private Clinics
Figure Drug Stores
Figure Retail Pharmacies
Figure E-Commerce
Figure Asthma & COPD Report Years Considered
Figure Global Asthma & COPD Market Size 2014-2025 (Million US$)
Figure Global Asthma & COPD Sales 2014-2025 (K Units)
Table Global Asthma & COPD Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Asthma & COPD Sales by Regions 2014-2019 (K Units)
Table Global Asthma & COPD Sales Market Share by Regions 2014-2019
Figure Global Asthma & COPD Sales Market Share by Regions 2014-2019
Figure 2018 Global Asthma & COPD Sales Market Share by Regions
Table Global Asthma & COPD Revenue by Regions 2014-2019 (Million US$)
Table Global Asthma & COPD Revenue Market Share by Regions 2014-2019
Figure Global Asthma & COPD Revenue Market Share by Regions 2014-2019
Figure 2018 Global Asthma & COPD Revenue Market Share by Regions
Table Global Asthma & COPD Sales by Manufacturers (2014-2019) (K Units)
Table Global Asthma & COPD Sales Share by Manufacturers (2014-2019)
Figure Global Asthma & COPD Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Asthma & COPD Revenue by Manufacturers (2014-2019) (Million USD)
Table Asthma & COPD Revenue Share by Manufacturers (2014-2019)
Figure Asthma & COPD Value Share by Manufacturers in 2018
Table Key Manufacturers Asthma & COPD Price (2014-2019) (USD/Unit)
Table Asthma & COPD Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Asthma & COPD Product Type
Table Date of International Manufacturers Enter into Asthma & COPD Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Asthma & COPD Sales by Product (2014-2019) (K Units)
Table Global Asthma & COPD Sales Share by Product (2014-2019)
Figure Global Asthma & COPD Sales Market Share by Product (2014-2019)
Figure Global Asthma & COPD Sales Market Share by Product in 2018
Table Global Asthma & COPD Revenue by Product (2014-2019) (Million US$)
Table Global Asthma & COPD Revenue Share by Product (2014-2019)
Figure Global Asthma & COPD Revenue Market Share by Product (2014-2019)
Figure Global Asthma & COPD Revenue Market Share by Product in 2018
Table Asthma & COPD Price by Product 2014-2019 (USD/Unit)
Table Global Asthma & COPD Sales by End User (2014-2019) (K Units)
Table Global Asthma & COPD Sales Share by End User (2014-2019)
Figure Global Sales Asthma & COPD Market Share by End User (2014-2019)
Figure Global Sales Asthma & COPD Market Share by End User in 2018
Figure North America Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
Figure North America Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
Table North America Asthma & COPD Sales by Countries (2014-2019) (K Units)
Table North America Asthma & COPD Sales Market Share by Countries (2014-2019)
Figure 2018 North America Asthma & COPD Sales Market Share by Countries
Table North America Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
Table North America Asthma & COPD Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Asthma & COPD Revenue Market Share by Countries
Figure United States Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure United States Asthma & COPD Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Canada Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Table North America Asthma & COPD Sales by Product (2014-2019) (K Units)
Table North America Asthma & COPD Sales Market Share by Product (2014-2019)
Figure 2018 North America Asthma & COPD Market Share by Product
Table North America Asthma & COPD Sales by End User (2014-2019) (K Units)
Table North America Asthma & COPD Sales Market Share by End User (2014-2019)
Figure 2018 North America Asthma & COPD Market Share by End User
Figure Europe Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
Figure Europe Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Asthma & COPD Sales by Countries (2014-2019) (K Units)
Table Europe Asthma & COPD Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Asthma & COPD Sales Market Share by Countries
Table Europe Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
Table Europe Asthma & COPD Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Asthma & COPD Revenue Market Share by Countries
Figure Germany Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Germany Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure France Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure France Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure UK Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Italy Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Russia Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Asthma & COPD Sales by Product (2014-2019) (K Units)
Table Europe Asthma & COPD Sales Market Share by Product (2014-2019)
Figure 2018 Europe Asthma & COPD Market Share by Product
Table Europe Asthma & COPD Sales by End User (2014-2019) (K Units)
Table Europe Asthma & COPD Sales Market Share by End User (2014-2019)
Figure 2018 Europe Asthma & COPD Market Share by End User
Figure Asia Pacific Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Asthma & COPD Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Asthma & COPD Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Asthma & COPD Sales Market Share by Countries
Table Asia Pacific Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Asthma & COPD Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Asthma & COPD Revenue Market Share by Countries
Figure China Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure China Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Japan Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Korea Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure India Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure India Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Australia Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Asthma & COPD Sales by Product (2014-2019) (K Units)
Table Asia Pacific Asthma & COPD Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Asthma & COPD Market Share by Product
Table Asia Pacific Asthma & COPD Sales by End User (2014-2019) (K Units)
Table Asia Pacific Asthma & COPD Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Asthma & COPD Market Share by End User
Figure Central & South America Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Asthma & COPD Sales by Countries (2014-2019) (K Units)
Table Central & South America Asthma & COPD Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Asthma & COPD Sales Market Share by Countries
Table Central & South America Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Asthma & COPD Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Asthma & COPD Revenue Market Share by Countries
Figure Brazil Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Asthma & COPD Sales by Product (2014-2019) (K Units)
Table Central & South America Asthma & COPD Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Asthma & COPD Market Share by Product
Table Central & South America Asthma & COPD Sales by End User (2014-2019) (K Units)
Table Central & South America Asthma & COPD Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Asthma & COPD Market Share by End User
Figure Middle East and Africa Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Asthma & COPD Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Asthma & COPD Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Asthma & COPD Sales Market Share by Countries
Table Middle East and Africa Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Asthma & COPD Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Asthma & COPD Revenue Market Share by Countries
Figure GCC Countries Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Asthma & COPD Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Asthma & COPD Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Asthma & COPD Market Share by Product
Table Middle East and Africa Asthma & COPD Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Asthma & COPD Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Asthma & COPD Market Share by End User
Table GSK Company Details
Table GSK Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Abbott Company Details
Table Abbott Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Roche Company Details
Table Roche Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Teva Company Details
Table Teva Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Recent Development
Table Vectura Company Details
Table Vectura Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Vectura Recent Development
Table Pfizer Company Details
Table Pfizer Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Mylan Company Details
Table Allergan Company Details
Table Cipla Company Details
Table Akorn Company Details
Table Global Asthma & COPD Sales Forecast by Regions 2019-2025 (K Units)
Table Global Asthma & COPD Sales Market Share Forecast by Regions 2019-2025
Table Global Asthma & COPD Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Asthma & COPD Revenue Market Share Forecast by Regions 2019-2025
Table Global Asthma & COPD Sales Forecast by Product 2019-2025 (K Units)
Table Global Asthma & COPD Sales Market Share Forecast by Product 2019-2025
Table Global Asthma & COPD Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Asthma & COPD Revenue Market Share Forecast by Product 2019-2025
Table Global Asthma & COPD Sales Forecast by End User 2019-2025 (K Units)
Table Global Asthma & COPD Sales Market Share Forecast by End User 2019-2025
Figure North America Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Asthma & COPD Value Chain
Table Asthma & COPD Customers List
Table Asthma & COPD Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs